Clinical Trial Update: Lansoprazole for Subgroups of Functional Dyspepsia [Phase 4]

View source ↗

Summary

Phase 4 study evaluating lansoprazole for subgroups of functional dyspepsia has been terminated (NCT01040455). Sponsor: National Taiwan University Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• Lansoprazole (Lansoprazole)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Functional Dyspepsia | Phase 4 | Status: TERMINATED